|国家科技期刊平台
首页|期刊导航|现代中医临床|盆腔炎性疾病及其后遗症的中西医治疗现状及问题探析

盆腔炎性疾病及其后遗症的中西医治疗现状及问题探析OACSTPCD

Analysis of the current situation and problems of traditional Chinese and Western medicine treatment for pelvic inflammatory diseases and their sequelae

中文摘要英文摘要

目的 调查盆腔炎性疾病(pelvic inflammatory disease,PID)及其后遗症的中西医治疗现状并分析存在的问题.方法 以成都中医药大学附属医院为牵头单位,采用多中心横断面研究方法、纸质版问卷调查方式收集全国 22 家医疗单位的PID及盆腔炎性疾病后遗症(sequelae of pelvic in-flammatory disease,SPID)病例进行中西医治疗现状分析,运用SPSS 26.0 软件分析数据.结果 本研究共采集病例 1 601 例,在目前治疗中,53.3%患者使用了抗生素,静脉抗生素种类频次最多为头孢菌素类+硝咪唑类(62.2%).98.0%患者使用了中药汤剂,其中PID使用频次前 3 依次为:四逆四妙散(35.2%)、仙方活命饮(10.0%)、银翘红酱解毒汤(6.4%),SPID使用频次前 3依次为四逆四妙散(28.9%)、膈下逐瘀汤(9.4%)、杜断桑寄失笑散(8.3%).63.6%患者使用了中成药,其中PID使用频次前 3 为妇科千金片(12.1%)、金刚藤胶囊(10.0%)、妇炎康复胶囊(5.6%),SPID 使用频次前 3 为妇科千金片(13.5%)、桂枝茯苓丸(8.4%)、妇可靖胶囊(6.6%).50.4%患者使用了中医外治法,以中药直肠导入最多见(31.1%).结论 PID患者主要以抗生素联合中医药的中西医结合方案为主,SPID患者以中医治疗为主,目前抗生素、中成药、中医外治法仍存在使用不规范的情况,临床需进一步推进其规范化使用,探索有效的中西医结合治疗方案.

Objective To investigate the current status of traditional Chinese and Western medicine treatments for pelvic inflammatory disease(PID)and its sequelae(SPID)and to analyze existing problems.Methods Led by the Hospital of Chengdu University of Traditional Chinese Medicine,a multicenter cross-sectional study was conducted.Data were collected through paper-based questionnaires from 22 medical units nationwide,encompassing cases of PID and SPID.The data were analyzed using SPSS 26.0 software.Results A total of 1601 cases were collected.Currently,53.3%of patients use antibiotics,with cephalosporins and nitroimidazoles being the most frequently administered intravenously(62.2%).Additionally,98.0%of patients use traditional Chinese medicine decoctions,with the top three formulas for PID being Sini Simiao Powder(Frigid Extremities Plus Wonderfully Effective Four Powder)(35.2%),Xianfang Huoming Beverage(Immortal Formula Life-Giving Beverage)(10.0%),and Yinqiao Hongjiang Jiedu Decoction(Lonicera,Forsythia,Sargent Gloryvine and Patrinia Toxin-Resolving Decoction)(6.4%).For SPID,the most commonly used decoctions are Sini Simiao Powder(28.9%),Gexia Zhuyu Decoction(Expelling Stasis Below the Diaphragm Decoction)(9.4%),and Duduansang Jishixiao Powder(Eucommia,Himalayan Teasel,and Taxillus Sudden Smile Powder)(8.3%).Moreover,63.6%of patients use traditional Chinese patent medicines,with the top three for PID being Fuke Qianjin Tablets(12.1%),Jingangteng Capsules(10.0%),and Fuyankang Capsules(5.6%).For SPID,the top three are Fuke Qianjin Tablets(13.5%),Guizhi Fuling Pills(8.4%),and Fukejing Capsules(6.6%).Furthermore,50.4%of patients use traditional Chinese medicine external treatments,with the highest frequency being traditional Chinese medicine rectal introduction(31.1%).Conclusion PID patients primarily rely on a combination of antibiotics and traditional Chinese medicine,while SPID patients are mainly treated with TCM.There are still issues of inappropriate use of antibiotics,traditional Chinese patent medicines,and external treatments.It is essential to promote standardized clinical use and explore effective integrated traditional and Western medicine treatment schemes.

蔡福梅;魏绍斌;李茂雅;刘雪梅;罗艺苹;钟函芝;程文秀;甘雨玉

成都中医药大学附属医院 成都 610075

中医学

盆腔炎性疾病盆腔炎性疾病后遗症中西医治疗现状横断面研究

pelvic inflammatory diseasesequelae of pelvic inflammatory diseasecurrent situation of traditional Chinese and Western medicine treatmentcross-sectional study

《现代中医临床》 2024 (004)

1-7 / 7

国家自然科学基金项目(No.82174431);国家中医药管理局全国名老中医药专家传承工作室建设项目(No.国中医药人教函12022175号)

10.3969/j.issn.2095-6606.2024.04.001

评论